In the purpurin-treated ischemic group, IL-1β, IL-6, and TNF-α levels were significantly lower than those in vehicle-treated ischemic group and were 203.2%, 178.2%, and 626.1% of those in the control group 6 h after ischemia, respectively. The gene discussed is IL1B; the disease is ischemia.